SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

AstroNova, Inc. – ‘10-Q’ for 11/2/19

On:  Tuesday, 12/10/19, at 10:46am ET   ·   For:  11/2/19   ·   Accession #:  1193125-19-309951   ·   File #:  0-13200

Previous ‘10-Q’:  ‘10-Q’ on 9/9/19 for 8/3/19   ·   Next:  ‘10-Q’ on 6/26/20 for 5/2/20   ·   Latest:  ‘10-Q’ on 12/6/23 for 10/28/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/10/19  AstroNova, Inc.                   10-Q       11/02/19   90:6.2M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    424K 
 2: EX-10.1     Material Contract                                   HTML     63K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     27K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     27K 
24: R1          Cover Page                                          HTML     62K 
58: R2          Condensed Consolidated Balance Sheets               HTML    131K 
84: R3          Condensed Consolidated Balance Sheets               HTML     36K 
                (Parenthetical)                                                  
37: R4          Condensed Consolidated Statements of Income         HTML     79K 
23: R5          Condensed Consolidated Statements of Comprehensive  HTML     53K 
                Income                                                           
56: R6          Condensed Consolidated Statements of Changes in     HTML     96K 
                Shareholders' Equity                                             
82: R7          Condensed Consolidated Statements of Changes in     HTML     29K 
                Shareholders' Equity (Parenthetical)                             
35: R8          Condensed Consolidated Statements of Cash Flows     HTML    113K 
26: R9          Business and Basis of Presentation                  HTML     38K 
44: R10         Summary of Significant Accounting Policies Update   HTML     35K 
16: R11         Revenue Recognition                                 HTML     82K 
66: R12         Net Income Per Common Share                         HTML     47K 
75: R13         Intangible Assets                                   HTML    101K 
43: R14         Inventories                                         HTML     43K 
15: R15         Revolving Line of Credit                            HTML     32K 
65: R16         Debt                                                HTML     53K 
74: R17         Derivative Financial Instruments and Risk           HTML     81K 
                Management                                                       
45: R18         Royalty Obligation                                  HTML     31K 
13: R19         Leases                                              HTML     77K 
61: R20         Accumulated Other Comprehensive Loss                HTML     49K 
89: R21         Share-Based Compensation                            HTML    119K 
42: R22         Income Taxes                                        HTML     40K 
33: R23         Segment Information                                 HTML    105K 
60: R24         Fair Value                                          HTML    112K 
88: R25         Subsequent Event                                    HTML     30K 
41: R26         Summary of Significant Accounting Policies Update   HTML     41K 
                (Policies)                                                       
32: R27         Revenue Recognition (Tables)                        HTML     76K 
59: R28         Net Income Per Common Share (Tables)                HTML     46K 
90: R29         Intangible Assets (Tables)                          HTML    103K 
72: R30         Inventories (Tables)                                HTML     45K 
62: R31         Debt (Tables)                                       HTML     53K 
17: R32         Derivative Financial Instruments and Risk           HTML     81K 
                Management (Tables)                                              
46: R33         Leases (Tables)                                     HTML     79K 
73: R34         Accumulated Other Comprehensive Loss (Tables)       HTML     48K 
63: R35         Share-Based Compensation (Tables)                   HTML    121K 
18: R36         Income Taxes (Tables)                               HTML     32K 
47: R37         Segment Information (Tables)                        HTML    105K 
71: R38         Fair Value (Tables)                                 HTML    110K 
64: R39         Business and Basis of Presentation - Additional     HTML     26K 
                Information (Detail)                                             
85: R40         Revenue Recognition - Summary of Revenues           HTML     43K 
                Disaggregated by Primary Geographic Markets                      
                (Detail)                                                         
54: R41         Revenue Recognition - Summary of Revenues           HTML     36K 
                Disaggregated by Primary Product Type (Detail)                   
25: R42         Revenue Recognition - Additional Information        HTML     48K 
                (Detail)                                                         
34: R43         Net Income Per Common Share - Reconciliation of     HTML     33K 
                Shares Used in Calculating Basic and Diluted                     
                (Detail)                                                         
86: R44         Net Income Per Common Share - Additional            HTML     27K 
                Information (Detail)                                             
55: R45         Intangible Assets - Fair Value of Acquired          HTML     56K 
                Identifiable Intangible Assets and Related                       
                Estimated Useful Lives (Detail)                                  
27: R46         Intangible Assets - Additional Information          HTML     33K 
                (Detail)                                                         
36: R47         Intangible Assets - Summary of Estimated            HTML     38K 
                Amortization Expense (Detail)                                    
83: R48         Inventories - Components of Inventories (Detail)    HTML     42K 
57: R49         Revolving Credit Facility - Additional Information  HTML     65K 
                (Detail)                                                         
70: R50         Debt - Schedule of Long Term Debt in the            HTML     42K 
                Accompanying Condensed Consolidated Balance Sheets               
                (Detail)                                                         
78: R51         Debt - Schedule of Long Term Debt in the            HTML     41K 
                Accompanying Condensed Consolidated Balance Sheets               
                (Parenthetical) (Detail)                                         
49: R52         Debt - Schedule of Required Principal Payments      HTML     45K 
                Remaining on Long Term Debt Outstanding (Detail)                 
20: R53         Derivative Financial Instruments and Risk           HTML     56K 
                Management - Schedule of Impact of the Derivative                
                Instruments in the Condensed Consolidated                        
                Financial Statements (Detail)                                    
69: R54         Derivative Financial Instruments and Risk           HTML     32K 
                Management - Additional Information (Detail)                     
77: R55         Royalty Obligation - Additional Information         HTML     43K 
                (Detail)                                                         
48: R56         Leases - Additional Information (Detail)            HTML     48K 
19: R57         Leases - Schedule Of Balance Sheet And Other        HTML     32K 
                Information Related To Operating Leases (Detail)                 
68: R58         Leases - Lease Cost Information (Detail)            HTML     28K 
79: R59         Leases - Maturities of lease liabilities (Detail)   HTML     45K 
39: R60         Leases - Supplemental cash flow information         HTML     28K 
                (Detail)                                                         
30: R61         Leases - Future minimum operating lease             HTML     45K 
                commitments (Detail)                                             
53: R62         Accumulated Other Comprehensive Loss - Changes in   HTML     59K 
                Balance of Accumulated Other Comprehensive Loss                  
                (Detail)                                                         
81: R63         Share-Based Compensation - Additional Information   HTML    109K 
                (Detail)                                                         
38: R64         Share-Based Compensation - Share-Based              HTML     35K 
                Compensation Expense (Detail)                                    
29: R65         Share-Based Compensation - Fair Value of Stock      HTML     37K 
                Options Granted (Detail)                                         
52: R66         Share-Based Compensation - Aggregated Information   HTML     48K 
                Regarding Stock Options Granted (Detail)                         
80: R67         Share-Based Compensation - Summary of Options       HTML     68K 
                Outstanding (Detail)                                             
40: R68         Share-Based Compensation - Aggregated Information   HTML     50K 
                Regarding RSUs and RSAs Granted (Detail)                         
28: R69         Income Taxes - Projected Effective Tax Rate for     HTML     30K 
                Periods (Detail)                                                 
21: R70         Income Taxes - Additional Information (Detail)      HTML     39K 
50: R71         Segment Information - Net Sales and Segment         HTML     63K 
                Operating Profit for Each Reporting Segment                      
                (Detail)                                                         
76: R72         Fair Value - Summary of Financial Assets and        HTML     49K 
                Liabilities Measured at Fair Value (Detail)                      
67: R73         Fair Value - Additional Information (Detail)        HTML     44K 
22: R74         Fair Value - Schedule of Company's Long-Term Debt   HTML     35K 
                Including the Current Portion Not Reflected in                   
                Financial Statements at Fair Value (Detail)                      
51: R75         Subsequent Event - Additional Information (Detail)  HTML     34K 
87: XML         IDEA XML File -- Filing Summary                      XML    163K 
14: EXCEL       IDEA Workbook of Financial Reports                  XLSX     77K 
 7: EX-101.INS  XBRL Instance -- alot-20191102                       XML   2.21M 
 9: EX-101.CAL  XBRL Calculations -- alot-20191102_cal               XML    162K 
10: EX-101.DEF  XBRL Definitions -- alot-20191102_def                XML    530K 
11: EX-101.LAB  XBRL Labels -- alot-20191102_lab                     XML   1.08M 
12: EX-101.PRE  XBRL Presentations -- alot-20191102_pre              XML    850K 
 8: EX-101.SCH  XBRL Schema -- alot-20191102                         XSD    162K 
31: ZIP         XBRL Zipped Folder -- 0001193125-19-309951-xbrl      Zip    149K 


‘10-Q’   —   Quarterly Report
Document Table of Contents

Page (sequential)   (alphabetic) Top
 
11st Page  –  Filing Submission
"Table of Contents
"Financial Information
"Financial Statements
"Unaudited Condensed Consolidated Balance Sheets -- November 2, 2019 and January 31, 2019
"Unaudited Condensed Consolidated Statements of Income -- Three and Nine Months Ended November 2, 2019 and October 27, 2018
"Unaudited Condensed Consolidated Statements of Comprehensive Income -- Three and Nine Months Ended November 2, 2019 and October 27, 2018
"Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity -- Three and Nine Months Ended November 2, 2019 and October 27, 2018
"Unaudited Condensed Consolidated Statements of Cash Flows -- Nine Months Ended November 2, 2019 and October 27, 2018
"Notes to the Condensed Consolidated Financial Statements (unaudited)
"Management's Discussion and Analysis of Financial Condition and Results of Operations
"Quantitative and Qualitative Disclosures about Market Risk
"Controls and Procedures
"Other Information
"Legal Proceedings
"Risk Factors
"Exhibits
"Signatures

This is an HTML Document rendered as filed.  [ Alternative Formats ]



  10-Q  
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended November 2, 2019

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number 0-13200

 

 

AstroNova, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Rhode Island   05-0318215

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

600 East Greenwich Avenue, West Warwick, Rhode Island   02893
(Address of principal executive offices)   (Zip Code)

(401) 828-4000

(Registrant’s telephone number, including area code)

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol

 

Name of each exchange

on which registered

Common Stock, $.05 Par Value   ALOT   NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐.

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)    Yes  ☐    No  ☒.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

The number of shares of the registrant’s common stock, $.05 par value per share, outstanding as of December 5, 2019 was 7,069,568.

 

 

 


Table of Contents

ASTRONOVA, INC.

INDEX

 

         Page No.  

Part I.

  Financial Information   

Item 1.

  Financial Statements   
  Unaudited Condensed Consolidated Balance Sheets – November 2, 2019 and January 31, 2019      3  
 

Unaudited Condensed Consolidated Statements of Income — Three and Nine Months Ended November 2, 2019 and October 27, 2018

     4  
 

Unaudited Condensed Consolidated Statements of Comprehensive Income — Three and Nine Months Ended November 2, 2019 and October 27, 2018

     5  
 

Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity — Three and Nine Months Ended November 2, 2019 and October 27, 2018

     6-7  
  Unaudited Condensed Consolidated Statements of Cash Flows — Nine Months Ended November 2, 2019 and October 27, 2018      8  
  Notes to the Condensed Consolidated Financial Statements (unaudited)      9-23  

Item 2.

  Management’s Discussion and Analysis of Financial Condition and Results of Operations      24-31  

Item 3.

  Quantitative and Qualitative Disclosures about Market Risk      31  

Item 4.

  Controls and Procedures      31  

Part II.

  Other Information   

Item 1.

  Legal Proceedings      32  

Item 1A.

  Risk Factors      32  

Item 5.

  Other Information      32  

Item 6.

  Exhibits      33  

Signatures

     34  

 

2


Table of Contents

Part I. FINANCIAL INFORMATION

 

Item 1.

Financial Statements

ASTRONOVA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, Except Share Data)

 

     November 2,
2019
    January 31,
2019
 
     (Unaudited)        

ASSETS

    

CURRENT ASSETS

    

Cash and Cash Equivalents

   $ 4,468     $ 7,534  

Accounts Receivable, net

     22,094       23,486  

Inventories, net

     35,594       30,161  

Prepaid Expenses and Other Current Assets

     3,059       1,427  
  

 

 

   

 

 

 

Total Current Assets

     65,215       62,608  

Property, Plant and Equipment, net

     11,323       10,380  

Intangible Assets, net

     26,454       29,674  

Goodwill

     12,110       12,329  

Deferred Tax Assets, net

     3,482       2,928  

Right of Use Assets

     1,767       —    

Other Assets

     1,014       1,064  
  

 

 

   

 

 

 

TOTAL ASSETS

   $  121,365     $  118,983  
  

 

 

   

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

    

CURRENT LIABILITIES

    

Accounts Payable

   $ 6,674     $ 5,956  

Accrued Compensation

     2,968       5,023  

Other Liabilities and Accrued Expenses

     3,789       2,911  

Current Portion of Long-Term Debt

     5,116       5,208  

Revolving Credit Facility

     6,500       1,500  

Current Liability – Royalty Obligation

     2,000       1,875  

Current Liability – Excess Royalty Payment Due

     419       1,265  

Deferred Revenue

     387       373  

Income Taxes Payable

     —         554  
  

 

 

   

 

 

 

Total Current Liabilities

     27,853       24,665  

Long-Term Debt, net of current portion

     9,004       12,870  

Royalty Obligation, net of current portion

     8,488       9,916  

Lease Liabilities, net of current portion

     1,350       —    

Deferred Tax Liabilities

     539       40  

Other Long-Term Liabilities

     1,178       1,717  
  

 

 

   

 

 

 

TOTAL LIABILITIES

     48,412       49,208  

SHAREHOLDERS’ EQUITY

    

Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 10,333,915 shares and 10,218,559 shares at November 2, 2019 and January 31, 2019, respectively

     518       511  

Additional Paid-in Capital

     55,870       53,568  

Retained Earnings

     51,142       49,511  

Treasury Stock, at Cost, 3,279,831 and 3,261,672 shares at November 2, 2019 and January 31, 2019, respectively

     (33,454     (32,997

Accumulated Other Comprehensive Loss, net of tax

     (1,123     (818
  

 

 

   

 

 

 

TOTAL SHAREHOLDERS’ EQUITY

     72,953       69,775  
  

 

 

   

 

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

   $ 121,365     $ 118,983  
  

 

 

   

 

 

 

See Notes to condensed consolidated financial statements (unaudited).

 

3


Table of Contents

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, Except Per Share Data)

(Unaudited)

 

     Three Months Ended     Nine Months Ended  
     November 2,
2019
    October 27,
2018
    November 2,
2019
    October 27,
2018
 

Revenue

   $  33,318     $  34,196     $  102,967     $  99,490  

Cost of Revenue

     21,021       20,288       64,454       60,073  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross Profit

     12,297       13,908       38,513       39,417  

Operating Expenses:

        

Selling and Marketing

     6,944       6,587       20,122       19,484  

Research and Development

     2,076       2,123       5,868       5,844  

General and Administrative

     2,830       2,836       8,445       8,298  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating Expenses

     11,850       11,546       34,435       33,626  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating Income

     447       2,362       4,078       5,791  

Other Expense, net

     (238     (538     (788     (1,320
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before Income Taxes

     209       1,824       3,290       4,471  

Income Tax (Benefit) Provision

     (247     407       182       1,046  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net Income

   $ 456     $ 1,417     $ 3,108     $ 3,425  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net Income per Common Share—Basic:

   $ 0.06     $ 0.21     $ 0.44     $ 0.50  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net Income per Common Share—Diluted:

   $ 0.06     $ 0.20     $ 0.43     $ 0.49  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted Average Number of Common Shares Outstanding:

        

Basic

     7,047       6,925       7,013       6,858  

Diluted

     7,199       7,167       7,272       7,056  

See Notes to condensed consolidated financial statements (unaudited).

 

4


Table of Contents

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Thousands)

(Unaudited)

 

     Three Months
Ended
    Nine Months
Ended
 
     November 2,
2019
     October 27,
2018
    November 2,
2019
    October 27,
2018
 

Net Income

   $  456      $ 1,417     $ 3,108     $ 3,425  

Other Comprehensive Income (Loss), Net of Taxes and Reclassification Adjustments:

         

Foreign Currency Translation Adjustments

     87        (157     (166     (775

Change in Value of Derivatives Designated as Cash Flow Hedge

     62        221       62       766  

Losses (Gains) from Cash Flow Hedges Reclassified to Income Statement

     3        (150     (201     (605

Realized Loss on Securities Available for Sale Reclassified to Income Statement

     —          —         —         3  
  

 

 

    

 

 

   

 

 

   

 

 

 

Other Comprehensive Income (Loss)

     152        (86     (305     (611
  

 

 

    

 

 

   

 

 

   

 

 

 

Comprehensive Income

   $ 608      $ 1,331     $ 2,803     $ 2,814  
  

 

 

    

 

 

   

 

 

   

 

 

 

See Notes to condensed consolidated financial statements (unaudited).

 

5


Table of Contents

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

($ In Thousands, Except per Share Data)

(Unaudited)

 

     Common Stock      Additional
Paid-in
Capital
    Retained
Earnings
    Treasury
Stock
    Accumulated
Other
Comprehensive
Income (Loss)
    Total
Shareholders’
Equity
 
     Shares      Amount  

Balance February 1, 2019

     10,218,559      $ 511      $ 53,568     $ 49,511     $  (32,997   $ (818   $ 69,775  

Share-Based Compensation

     —          —          601       —         —         —         601  

Employee Option Exercises

     27,990        1        306       —         (11     —         296  

Restricted Stock Awards Vested, net

     9,522        1        (1     —         (69     —         (69

Cash Dividend—$0.07 per share

     —          —          —         (489     —         —         (489

Net Income

     —          —          —         1,700       —         —         1,700  

Other Comprehensive Loss

     —          —          —         —         —         (200     (200
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance May 4, 2019

     10,256,071      $ 513      $ 54,474     $ 50,722     $  (33,077   $  (1,018   $ 71,614  

Share-Based Compensation

     —          —          451       —         —         —         451  

Employee Option Exercises

     13,821        1        198       —         —         —         199  

Restricted Stock Awards Vested, net

     45,658        2        (2     —         (377     —         (377

Cash Dividend—$0.07 per share

     —          —          —         (493     —         —         (493

Net Income

     —          —          —         951       —         —         951  

Other Comprehensive Loss

     —          —          —         —         —         (257     (257
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance August 3, 2019

     10,315,550      $ 516      $ 55,121     $ 51,180     $ (33,454   $ (1,275   $ 72,088  

Share-Based Compensation

     —          —          525       —         —         —         525  

Employee Option Exercises

     18,365        2        224       —         —         —         226  

Cash Dividend—$0.07 per share

     —          —          —         (494     —         —         (494

Net Income

     —          —          —         456       —         —         456  

Other Comprehensive Income

     —          —          —         —         —         152       152  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance November 2, 2019

     10,333,915      $  518      $  55,870     $  51,142     $ (33,454   $ (1,123   $  72,953  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

6


Table of Contents
     Common Stock      Additional
Paid-in
Capital
    Retained
Earnings
    Treasury
Stock
    Accumulated
Other
Comprehensive
Income (Loss)
    Total
Shareholders’
Equity
 
     Shares      Amount  

Balance February 1, 2018

     9,996,120      $ 500      $ 50,016     $ 45,700     $  (32,397   $ (172   $ 63,647  

Share-Based Compensation

     —          —          363       —         —         —         363  

Employee Option Exercises

     53,010        3        574       —         (88     —         489  

Restricted Stock Awards Vested, net

     16,981        1        (1     —         (40     —         (40

Cash Dividend—$0.07 per share

     —          —          —         (480     —         —         (480

Net Income

     —          —          —         814       —         —         814  

Other Comprehensive Loss

     —          —          —         —         —         (163     (163
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance April 28, 2018

     10,066,111      $  504      $  50,952     $  46,034     $  (32,525   $  (335   $  64,630  

Share-Based Compensation

     —          —          466       —         —         —         466  

Employee Option Exercises

     40,302        —          461       —         (278     —         183  

Restricted Stock Awards Vested, net

     30,084        3        (2     —         (157     —         (156

Cash Dividend—$0.07 per share

     —          —          —         (481     —         —         (481

Net Income

     —          —          —         1,194       —         —         1,194  

Reclassification of Certain Income Tax Effects from Accumulated Other Comprehensive Loss

     —          —          —         14       —         —         14  

Other Comprehensive Loss

     —          —          —         —         —         (362     (362
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance July 28, 2018

     10,136,497      $ 507      $ 51,877     $ 46,761     $  (32,960   $  (697   $ 65,488  

Share-Based Compensation

     —          —          510       —         —         —         510  

Employee Option Exercises

     54,952        3        561       —         —         —         564  

Restricted Stock Awards Vested, net

     5,306        —          —         —         —         —         —    

Cash Dividend—$0.07 per share

     —          —          —         (485     —         —         (485

Net Income

     —          —          —         1,417       —         —         1,417  

Other Comprehensive Loss

     —          —          —         —         —         (86     (86
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance October 27, 2018

     10,196,755      $ 510      $ 52,948     $ 47,693     $  (32,960   $  (783   $ 67,408  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

7


Table of Contents

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

(Unaudited)

 

     Nine Months Ended  
     November 2,
2019
    October 27,
2018
 

Cash Flows from Operating Activities:

    

Net Income

   $ 3,108     $ 3,425  

Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:

    

Depreciation and Amortization

     4,692       4,633  

Amortization of Debt Issuance Costs

     37       38  

Share-Based Compensation

     1,576       1,339  

Deferred Income Tax Provision

     —         (67

Changes in Assets and Liabilities:

    

Accounts Receivable

     1,296       248  

Inventories

     (5,412     (1,140

Income Taxes

     (2,639     (244

Accounts Payable and Accrued Expenses

     (1,586     (4,793

Other

     (84     (916
  

 

 

   

 

 

 

Net Cash Provided by Operating Activities

     988       2,523  

Cash Flows from Investing Activities:

    

Proceeds from Sales/Maturities of Securities Available for Sale

     —         1,511  

Honeywell Asset Purchase and License Agreement—TSA Agreement Payment

     —         (400

Additions to Property, Plant and Equipment

     (2,422     (1,902
  

 

 

   

 

 

 

Net Cash Used by Investing Activities

     (2,422     (791

Cash Flows from Financing Activities:

    

Net Cash Proceeds from Common Shares Issued Under Employee Benefit Plans and Employee Stock Option Plans, Net of Payment of Minimum Tax Withholdings

     276       1,041  

Borrowings under Revolving Credit Facility

     5,000       3,000  

Repayment under Revolving Credit Facility

     —         (1,500

Payment of Minimum Guarantee Royalty Obligation

     (1,375     (1,250

Principal Payments of Long-Term Debt

     (3,998     (4,012

Dividends Paid

     (1,477     (1,446
  

 

 

   

 

 

 

Net Cash Used by Financing Activities

     (1,574     (4,167
  

 

 

   

 

 

 

Effect of Exchange Rate Changes on Cash and Cash Equivalents

     (58     74  
  

 

 

   

 

 

 

Net Decrease in Cash and Cash Equivalents

     (3,066     (2,361

Cash and Cash Equivalents, Beginning of Period

     7,534       10,177  
  

 

 

   

 

 

 

Cash and Cash Equivalents, End of Period

   $ 4,468     $ 7,816  
  

 

 

   

 

 

 

Supplemental Disclosures of Cash Flow Information:

    

Cash Paid During the Period for Interest

   $ 350     $ 449  

Cash Paid During the Period for Income Taxes, Net of Refunds

   $ 2,746     $ 3,154  

Schedule of Non-Cash Financing Activities:

    

Value of Shares Received in Satisfaction of Option Exercise Price

   $ 11     $ 366  

See Notes to condensed consolidated financial statements (unaudited).

 

8


Table of Contents

ASTRONOVA, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 1 – Business and Basis of Presentation

Overview

Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are employed around the world in a wide range of applications in the aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation industries. In the United States, the Company has factory-trained direct field salespeople located in major cities from coast to coast. We also have direct field sales or service centers in Canada, China, Denmark, France, Germany, India, Malaysia, Mexico, Singapore, Spain and the United Kingdom staffed by our own employees and dedicated third-party contractors. Additionally, we utilize over 150 independent dealers and representatives selling and marketing our products in over 50 countries.

The business consists of two segments, Product Identification (“PI”) and Test & Measurement (“T&M”). The Product Identification segment offers a variety of hardware and software products and associated supplies that allow customers to mark, track and enhance the appearance of their products. PI includes specialty printing systems and supplies sold under the QuickLabel®, TrojanLabel® and GetLabels brand names. PI products are used in industrial and commercial product packaging, branding and labeling applications to print custom labels, packaging materials and corresponding visual content to enable our customers to digitally print on-demand in their own facilities. The Test & Measurement segment includes systems sold under the AstroNova® brand name as well as the Company’s line of aerospace flight deck printers. Products sold under the AstroNova brand enable our customers to acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats. In the aerospace market, the Company has a long history of using its data visualization technologies to provide networking systems and high-resolution light-weight flight deck and cabin printers.

Unless otherwise indicated, references to “AstroNova,” the “Company,” “we,” “our,” and “us” in this Quarterly Report on Form 10-Q refer to AstroNova, Inc. and its consolidated subsidiaries.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2019.

The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Some of the more significant estimates relate to revenue recognition, the allowances for doubtful accounts, inventory valuation, income taxes, impairment of long-lived assets and goodwill, share-based compensation, accrued expenses, lease accounting and warranty reserves. Management’s estimates are based on the facts and circumstances available at the time estimates are made, historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters. Consequently, actual results could differ from those estimates.

Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year.

Certain amounts in the prior year financial statements have been reclassified to conform to the current year’s presentation.

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

 

9


Table of Contents

Note 2 – Summary of Significant Accounting Policies Update

The accounting polices used in preparing the condensed consolidated financial statements in this Form 10-Q are the same as those used in preparing the Consolidated Financial Statements for the year ended January 31, 2019, except for the change resulting from the adoption of Accounting Standard Codification Topic 842 (“ASC 842”), Leases. See Note 11 for further details related to the new lease accounting policy as a result of this adoption.

Recently Adopted Accounting Pronouncements

Leases

In February 2019, the Company adopted the guidance issued by the Financial Accounting Standards Board (“FASB”) related to leases. See Note 11 for further details related to this adoption, including policy and expanded disclosure requirements.

Recent Accounting Standards Not Yet Adopted

Internal-Use Software

In August 2018, the FASB issued Accounting Standards Update (“ASU’) 2018-15, “Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.” ASU 2018-15 reduces complexity for the accounting for costs of implementing a cloud computing service arrangement and aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). This ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019 (Q1 fiscal 2021 for AstroNova), with early adoption permitted. Implementation should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company is currently evaluating the impact this new guidance will have on its consolidated financial statements.

Fair Value Measurement

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820), Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 modifies the disclosure requirements for fair value measurements by removing, modifying or adding certain disclosures. This ASU is effective for annual periods beginning after December 15, 2019 including interim periods within those fiscal years (Q1 fiscal 2021 for AstroNova), with early adoption permitted. The provisions of ASU 2018-13 relating to changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. The remaining provisions should be applied retrospectively to all periods presented upon their effective date. The Company is currently evaluating the impact this new guidance will have on its consolidated financial statements and related disclosures.

No other new accounting pronouncements, issued or effective during the nine months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

Note 3 – Revenue Recognition

We derive revenue from the sale of (i) hardware, including digital color label printers and specialty OEM printing systems, portable data acquisition systems and airborne printers used in the flight deck and cabin of military, commercial and business aircraft, (ii) related supplies required in the operation of the hardware, (iii) repairs and maintenance of hardware and (iv) service agreements.

 

10


Table of Contents

Revenues disaggregated by primary geographic markets and major product types are as follows:

Primary geographical markets:

 

     Three Months Ended      Nine Months Ended  
(In thousands)    November 2,
2019
     October 27,
2018
     November 2,
2019
     October 27,
2018
 

United States

   $  21,831      $  21,542      $ 64,471      $ 60,752  

Europe

     7,059        7,573        22,408        23,292  

Asia

     1,396        1,560        7,063        4,653  

Canada

     1,441        1,860        4,346        5,836  

Central and South America

     1,019        921        3,232        3,078  

Other

     572        740        1,447        1,879  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Revenue

   $ 33,318      $ 34,196      $  102,967      $  99,490  
  

 

 

    

 

 

    

 

 

    

 

 

 

Major product types:

 

     Three Months Ended      Nine Months Ended  
(In thousands)    November 2,
2019
     October 27,
2018
     November 2,
2019
     October 27,
2018
 

Hardware

   $  12,160      $  13,096      $  37,514      $  37,989  

Supplies

     17,655        18,107        55,463        52,690  

Service and Other

     3,503        2,993        9,990        8,811  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Revenue

   $ 33,318      $ 34,196      $ 1 02,967      $ 99,490  
  

 

 

    

 

 

    

 

 

    

 

 

 

Contract Assets and Liabilities

We normally do not have contract assets, which are primarily unbilled accounts receivable that are conditional on something other than the passage of time. Our contract liabilities, which represent billings in excess of revenue recognized, are related to advanced billings for purchased service agreements and extended warranties and were $387,000 and $373,000 at November 2, 2019 and January 31, 2019, respectively, and are recorded as deferred revenue in the condensed consolidated balance sheet. The Company recognized $279,000 of revenue during the nine month period ended November 2, 2019, related to the deferred revenue balance at January 31, 2019.

Contract Costs

We recognize an asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that certain costs related to obtaining sales contracts for our aerospace printer products meet the requirement to be capitalized. These costs are deferred and amortized based on the forecasted number of units sold over the estimated benefit term, which was estimated to be approximately 10 years. The balance of these contract assets at January 31, 2019 was $903,000. During the third quarter of the current year the Company recognized additional direct costs of $121,000. The Company amortized $82,000 of direct costs for the nine months ended November 2, 2019 and the balance of deferred incremental direct costs net of accumulated amortization at November 2, 2019 was $942,000, of which $117,000 is reported in other current assets and $825,000 is reported in other assets in the accompanying condensed consolidated balance sheet. The remaining contract costs are expected to be amortized over the estimated remaining period of benefit, which we currently estimate to be approximately seven years.

 

11


Table of Contents

Note 4 – Net Income Per Common Share

Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of shares and, if dilutive, common equivalent shares, determined using the treasury stock method for stock options, restricted stock awards and restricted stock units outstanding during the period. A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:

 

     Three Months Ended      Nine Months Ended  
     November 2,
2019
     October 27,
2018
     November 2,
2019
     October 27,
2018
 

Weighted Average Common Shares Outstanding – Basic

     7,046,803        6,924,554        7,012,595        6,858,365  

Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units

     151,795        242,074        259,840        197,760  
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted Average Common Shares Outstanding – Diluted

     7,198,598        7,166,628        7,272,435        7,056,125  
  

 

 

    

 

 

    

 

 

    

 

 

 

For the three and nine months ended November 2, 2019, the diluted per share amounts do not reflect common equivalent shares outstanding of 238,477 and 206,592, respectively. For the three and nine months ended October 27, 2018, the diluted per share amounts do not reflect common equivalent shares outstanding of 228,600 and 333,175, respectively. These outstanding common equivalent shares were not included due to their anti-dilutive effect.

Note 5 – Intangible Assets

Intangible assets are as follows:

 

     November 2, 2019      January 31, 2019  
(In thousands)    Gross
Carrying
Amount
     Accumulated
Amortization
    Currency
Translation
Adjustment
     Net
Carrying
Amount
     Gross
Carrying
Amount
     Accumulated
Amortization
    Currency
Translation
Adjustment
     Net
Carrying
Amount
 

Miltope:

                     

Customer Contract Relationships

   $ 3,100      $ (1,947   $ —        $ 1,153      $ 3,100      $  (1,723   $ —        $ 1,377  

RITEC:

                     

Customer Contract Relationships

     2,830        (988     —          1,842        2,830        (725     —          2,105  

Non-Competition Agreement

     950        (823     —          127        950        (681     —          269  

TrojanLabel:

                     

Existing Technology

     2,327        (968     92        1,451        2,327        (711     140        1,756  

Distributor Relations

     937        (273     34        698        937        (200     56        793  

Honeywell:

                     

Customer Contract Relationships

     27,243        (6,060     —          21,183        27,243        (3,869     —          23,374  
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Intangible Assets, net

   $  37,387      $  (11,059   $  126      $  26,454      $  37,387      $  (7,909   $  196      $  29,674  
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

There were no impairments to intangible assets during the periods ended November 2, 2019 and October 27, 2018. With respect to the acquired intangibles included in the table above, amortization expense of $1.1 million and $1.0 million has been included in the condensed consolidated statements of income for the three months ended November 2, 2019 and October 27, 2018, respectively. Amortization expense of $3.2 million and $3.1 million related to the above acquired intangibles has been included in the condensed consolidated statement of income for the nine months ended November 2, 2019 and October 27, 2018, respectively.

Estimated amortization expense for the next five fiscal years is as follows:

 

(In thousands)    Remaining
2020
     2021      2022      2023      2024  

Estimated amortization expense

   $  1,050      $  4,071      $  3,983      $  3,978      $  3,975  

 

12


Table of Contents

Note 6 – Inventories

Inventories are stated at the lower of cost (first-in, first-out) and net realizable value and include material, labor and manufacturing overhead. The components of inventories are as follows:

 

(In thousands)    November 2, 2019      January 31, 2019  

Materials and Supplies

   $  21,116      $  17,517  

Work-In-Process

     1,586        1,633  

Finished Goods

     18,170        15,688  
  

 

 

    

 

 

 
     40,872        34,838  

Inventory Reserve

     (5,278      (4,677
  

 

 

    

 

 

 
   $ 35,594      $ 30,161  
  

 

 

    

 

 

 

Note 7 – Revolving Line of Credit

The Company has a revolving line of credit under its existing Credit Agreement with Bank of America. Revolving credit loans may be borrowed, at the Company’s option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner. Amounts borrowed under the revolving credit facility bear interest at a rate per annum equal to, at the Company’s option, either (a) the LIBOR rate (or, in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.0% to 1.5% based on the Company’s consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal funds’ rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate or (iii) the LIBOR rate plus 1.00%, plus a margin that varies within a range of 0.0% to 0.5% based on the Company’s consolidated leverage ratio.

At November 2, 2019, $6.5 million has been drawn on the revolving line of credit. The outstanding balance bears interest at a weighted average annual rate of 5.26% and $93,000 and $39,000 of interest has been incurred on this obligation and included in other expense in the accompanying condensed consolidated income statement for the nine month periods ended November 2, 2019 and October 27, 2018, respectively. At November 2, 2019, there was $3.5 million available for borrowing under the revolving credit facility.

Following the completion of the third quarter of fiscal 2020, the Company entered into a Fourth Amendment to the Credit Agreement to, among other things, temporarily increase the revolving line of credit from $10.0 million to $17.5 million and modify certain of the financial covenants with which the Company must comply thereunder. For additional information on the amendment and the resulting changes to the terms of the agreement, see Note 17 – Subsequent Events.

The Company is required to pay a commitment fee on the undrawn portion of the revolving credit facility at the rate of 0.25% per annum.

Note 8 – Debt

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:

 

(In thousands)    November 2, 2019      January 31, 2019  

USD Term Loan (3.30% as of November 2, 2019 and 4.02% as of January 31, 2019); maturity date of November 20, 2022

   $ 9,000      $  11,250  

USD Term Loan (3.30% as of November 2, 2019 and 4.02% as of January 31, 2019); maturity date of January 31, 2022

     5,244        6,992  
  

 

 

    

 

 

 
   $  14,244      $ 18,242  

Debt Issuance Costs, net of accumulated amortization

     (124      (164

Current Portion of Term Loans

     (5,116      (5,208
  

 

 

    

 

 

 

Long-Term Debt

   $ 9,004      $ 12,870  
  

 

 

    

 

 

 

 

13


Table of Contents

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of November 2, 2019 is as follows:

 

(In thousands)       

Fiscal 2020, remainder

   $  1,210  

Fiscal 2021

     5,208  

Fiscal 2022

     5,576  

Fiscal 2023

     2,250  

Fiscal 2024

     —    
  

 

 

 
   $  14,244  
  

 

 

 

Following the completion of the third quarter of fiscal 2020, the Company entered into a Fourth Amendment to its Credit Agreement with Bank of America governing the Company’s long-term debt. Refer to Note 17 – Subsequent Events for additional information on the Fourth Amendment and the resulting changes to the terms of the Credit Agreement.

 

14


Table of Contents

Note 9 – Derivative Financial Instruments and Risk Management

The Company has entered into a cross-currency interest rate swap to manage the interest rate risk and foreign currency exchange risk associated with the floating-rate foreign currency-denominated term loan borrowing by our Danish Subsidiary and an interest rate swap to manage the interest rate risk associated with the variable rate term loan borrowing by the Company. Both swaps have been designated as cash flow hedges of floating-rate borrowings.

The cross-currency interest rate swap agreement utilized by the Company effectively modifies the Company’s exposure to interest rate risk and foreign currency exchange rate risk by converting the Company’s floating-rate debt denominated in U.S. Dollars on our Danish subsidiary’s books to a fixed-rate debt denominated in Danish Kroner for the term of the loan, thus reducing the impact of interest-rate and foreign currency exchange rate changes on future interest expense and principal repayments. This swap involves the receipt of floating rate amounts in U.S. Dollars in exchange for fixed-rate interest payments in Danish Kroner, as well as exchanges of principal at the inception spot rate, over the life of the term loan.

The interest rate swap agreement utilized by the Company on its term loan effectively modifies the Company’s exposure to interest rate risk by converting the Company’s floating-rate debt to fixed-rate debt for the next five years, thus reducing the impact of interest-rate changes on future interest expense. This swap involves the receipt of floating rate amounts in U.S. Dollars in exchange for fixed rate payments in U.S. dollars over the life of the term loan.

The following table summarizes the notional amount and fair value of the Company’s derivative instrument:

 

Cash Flow Hedges    November 2, 2019      January 31, 2019  

(In thousands)

          Fair Value Derivatives             Fair Value Derivatives  
     Notional Amount      Asset      Liability      Notional Amount      Asset      Liability  

Cross-currency Interest Rate Swap

   $  4,949      $ —        $  329      $ 6,329      $ —        $  600  

Interest Rate Swap

   $ 9,000      $ —        $ 88      $  11,250      $  85      $ —    

The following table presents the impact of the Company’s derivative instruments in our condensed consolidated financial statements for the three and nine months ended November 2, 2019 and October 27, 2018:

 

     Three Months Ended  
     Amount of Gain (Loss)
Recognized in OCI
on Derivative
     Location of
Gain (Loss)
Reclassified
from Accumulated
OCI into
Income (Expense)
   Amount of Gain (Loss)
Reclassified from
Accumulated OCI
into Income (Expense)
 

Cash Flow Hedge

(In thousands)

   November 2,
2019
     October 27,
2018
     November 2,
2019
    October 27,
2018
 

Swap Contracts

   $  80      $  283      Other Income (Expense)    $ (3   $  192  
  

 

 

    

 

 

       

 

 

   

 

 

 
     Nine Months Ended  
     Amount of Gain (Loss)
Recognized in OCI
on Derivative
     Location of
Gain (Loss)
Reclassified
from Accumulated
OCI into Income  (Expense)
   Amount of Gain (Loss)
Reclassified from
Accumulated OCI
into Income (Expense)
 

Cash Flow Hedge

(In thousands)

   November 2,
2019
     October 27,
2018
     November 2,
2019
    October 27,
2018
 

Swap Contracts

   $  82      $  981      Other Income (Expense)    $  259     $  775  
  

 

 

    

 

 

       

 

 

   

 

 

 

At November 2, 2019, the Company expects to reclassify approximately $0.2 million of net gains on the swap contracts from accumulated other comprehensive loss to earnings during the next 12 months due to changes in foreign exchange rates and the payment of variable interest associated with the floating-rate debt.

 

15


Table of Contents

Note 10 – Royalty Obligation

In fiscal 2018, AstroNova, Inc. entered into an Asset Purchase and License Agreement (the “Honeywell Agreement”) with Honeywell International, Inc. (“Honeywell”) to acquire an exclusive, perpetual, world-wide license to manufacture Honeywell’s narrow-format flight deck printers for two aircraft families along with certain inventory used in the manufacturing of the licensed printers. The purchase price included a guaranteed minimum royalty payment of $15.0 million, to be paid over ten years. Royalty payments are based on gross revenues from the sales of the printers, paper and repair services of the licensed products. The royalty rates vary based on the year in which they are paid or earned and product sold or service provided, and range from single-digit to mid double-digit percentages of gross revenue.

The guaranteed minimum royalty payment obligation was recorded at the present value of the minimum annual royalty payments using a present value factor of 2.8%, which is based on the estimated after-tax cost of debt for similar companies. As of November 2, 2019, the Company had paid an aggregate of $3.0 million of the guaranteed minimum royalty obligation. At November 2, 2019, the current portion of the outstanding guaranteed minimum royalty obligation of $2.0 million is to be paid over the next twelve months and is reported as a current liability and the remainder of $8.5 million is reported as a long-term liability on the Company’s condensed consolidated balance sheet. In addition to the guaranteed minimum royalty payments, the Company also incurred excess royalty expense of $0.1 million and $0.8 million, respectively, for the three and nine month periods ended November 2, 2019 and $0.7 million and $2.0 million, respectively, for the three and nine month periods ended October 27, 2018 which is included in cost of revenue in the Company’s condensed consolidated statements of income. A total of $0.4 million of excess royalty is payable and reported as a current liability on the Company’s condensed consolidated balance sheet at November 2, 2019.

Note 11 – Leases

Policy

On February 1, 2019 the Company adopted ASC 842, Leases. This new guidance requires a lessee to recognize assets and liabilities on the balance sheet for all leases, with the result being the recognition of a right of use (ROU) asset and a lease liability. The lease liability is equal to the present value of the minimum lease payments for the term of the lease, including any optional renewal periods determined to be reasonably certain to be exercised, using a discount rate determined at lease commencement. This discount rate is the rate implicit in the lease, if known; otherwise, the incremental borrowing rate for the expected lease term is used. The Company’s incremental borrowing rate approximates the rate the Company would have to pay to borrow on a collateralized basis over a similar term at lease inception. The value of the ROU asset is equal to the initial measurement of the lease liability plus any lease payments made to the lessor at or before the commencement date and any unamortized initial direct costs incurred by the lessee, less any unamortized lease incentives received.

There are two types of leases, operating leases and finance leases. Lease classification is determined at lease commencement. All of the Company’s leases are classified as operating leases. Operating lease expense is recognized on a straight-line basis over the lease term and included in general and administrative expense on the condensed consolidated statement of income. For operating leases, ROU assets are classified in other long-term assets, short-term lease liabilities are classified in other current liabilities, and long-term lease liabilities are classified in other long-term liabilities on the condensed consolidated balance sheet. On the cash flow statement, payments for operating leases are classified as operating activities.

The Company enters into lease contracts for certain of its facilities at various locations worldwide. At inception of a contract, the Company determines whether the contract is or contains a lease. If the Company has a right to obtain substantially all of the economic benefits from the use of the identified asset and the right to direct the use of the asset, then the contract contains a lease. Several of the Company’s lease contracts include options to extend the lease term and the Company includes the renewal options for these leases in the determination of the ROU asset and lease liability when the likelihood of renewal is determined to be reasonably certain.

 

16


Table of Contents

In addition, several of our lease agreements include non-lease components for items such as common area maintenance and utilities which are accounted for separately from the lease component.

Adoption Method and Impact

The Company applied ASC 842 to all leases in effect at February 1, 2019 and adopted the accounting standard using the non-comparative transition option, which does not require the restatement of prior years. Comparative information has not been adjusted and continues to be reported under the previous accounting guidance. The Company has elected the package of practical expedients, which allows entities to not reassess (1) whether contracts are or contain leases, (2) lease classification and (3) initial direct costs. The Company has made an accounting policy election to apply the short-term exception, which does not require the capitalization of leases with terms of 12 months or less. On February 1, 2019, the Company recognized $2.0 million of ROU assets and lease liabilities on its consolidated balance sheet. The adoption did not have a material impact on the Company’s results of operations or cash flows.

Disclosure

Our leases have remaining lease terms of 1 to 12 years, some of which include options to extend the lease term for periods up to five years when it is reasonably certain the Company will exercise such options.

The company leases office space from an affiliate. This lease is classified as an operating lease with annual rental payments of approximately $64,000 and $66,000 in fiscal 2020 and 2021, respectively.

Balance sheet and other information related to our leases is as follows:

 

Operating Leases

(In thousands)

   Balance Sheet Classification    November 2,
2019
 

Lease Assets

   Right of Use Assets    $  1,767  

Lease Liabilities – Current

   Other Liabilities and
Accrued Expenses
     429  

Lease Liabilities – Long Term

   Lease Liabilities      1,350  

Lease cost information is as follows:

 

          Three Months Ended      Nine Months Ended  

Operating Leases

(In thousands)

   Statement of Income Classification    November 2,
2019
     November 2,
2019
 

Operating Lease Costs

   General and Administrative Expense    $  119      $  329  

 

17


Table of Contents

Maturities of operating lease liabilities are as follows:

 

(In thousands)

   November 2,
2019
 

2020

   $ 94  

2021

     420  

2022

     354  

2023

     302  

2024

     275  

Thereafter

     564  
  

 

 

 

Total Lease Payments

     2,009  

Less: Imputed Interest

     (230
  

 

 

 

Total Lease Liabilities

   $  1,779  
  

 

 

 

As of November 2, 2019, the weighted-average remaining lease term and weighted-average discount rate for our operating leases are 5.7 years and 3.98%, respectively. We calculated the weighted-average discount rate using incremental borrowing rates, which equal the rates of interest that we would pay to borrow funds on a fully collateralized basis over a similar term.

Supplemental cash flow information related to leases is as follows:

 

     Three Months Ended      Nine Months Ended  

(In thousands)

   November 2,
2019
     November 2,
2019
 

Cash paid for amounts included in the measurement of lease liabilities:

   $  108      $  306  

As previously disclosed in our fiscal year 2019 Annual Report on Form 10-K and under the previous lease accounting standard, future minimum operating lease commitments that had initial or remaining non-cancelable lease terms in excess of one year at January 31, 2019 were as follows:

 

(In thousands)       

2020

   $  574  

2021

     520  

2022

     387  

2023

     294  

2024

     273  

Thereafter

     568  
  

 

 

 
     $ 2,616  
  

 

 

 

Note 12 – Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss (“AOCL”) by component are as follows:

 

(In thousands)

   Foreign Currency
Translation
Adjustments
     Cash
Flow
Hedges
     Total  

Balance at January 31, 2019

   $ (852    $ 34      $ (818

Other Comprehensive Loss before reclassification

     (166      62        (104

Amounts reclassified from AOCL to Earnings

     0        (201      (201
  

 

 

    

 

 

    

 

 

 

Other Comprehensive Loss

     (166      (139      (305
  

 

 

    

 

 

    

 

 

 

Balance at November 2, 2019

   $  (1,018    $  (105    $  (1,123
  

 

 

    

 

 

    

 

 

 

 

18


Table of Contents

The amounts presented above in other comprehensive loss are net of taxes except for translation adjustments associated with our German and Danish subsidiaries.

Note 13 – Share-Based Compensation

We have one equity incentive plan from which we are authorized to grant equity awards, the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards, including incentive stock options, non-qualified stock options, stock appreciation rights, time or performance-based restricted stock units (PSUs), restricted stock units (RSUs) and restricted stock awards (RSAs). At our annual meeting of shareholders held on June 4, 2019, the 2018 Plan was amended to increase the number of shares of the Company’s common stock available for issuance by 300,000, bringing the total number of shares available for issuance under the 2018 Plan from 650,000 to 950,000, plus an additional number of shares equal to the number of shares subject to awards granted under previous equity incentive plans that are forfeited, cancelled, satisfied without the issuance of stock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to any unvested award, reacquired by the Company at not more than the grantee’s purchase price (other than by exercise). Under the 2018 Plan, all awards to employees generally have a minimum vesting period of one year. Options granted under the 2018 Plan must be issued at an exercise price of not less than the fair market value of the Company’s common stock on the date of grant and expire after ten years. As of November 2, 2019, 161,375 unvested shares of restricted stock and options to purchase an aggregate of 146,000 shares were outstanding under the 2018 Plan.

In addition to the 2018 Plan, we previously granted equity awards under our 2015 Equity Incentive Plan (the “2015 Plan”) and our 2007 Equity Incentive Plan (the “2007 Plan”). Both the 2007 Plan and the 2015 Plan have expired and no new awards may be issued under either, but outstanding awards will continue to be governed by those plans. As of November 2, 2019, 1,007 unvested shares of restricted stock and options to purchase an aggregate of 376,645 shares were outstanding under the 2007 Plan and 27,527 unvested shares of restricted stock and options to purchase an aggregate of 184,650 shares were outstanding under the 2015 Plan.

On January 31, 2019, the compensation committee of the Company’s board of directors adopted an Amended and Restated Non-Employee Director Annual Compensation Program (the “New Program”), which became effective as of February 1, 2019 and supersedes the prior program. Pursuant to the New Program, beginning with fiscal 2020, each non-employee director will automatically receive a grant of restricted stock on the date of their re-election to the Company’s board of directors. The number of whole shares to be granted will be equal to the number calculated by dividing the stock component of the director compensation amount determined by the compensation committee for that year by the fair market value of our stock on that day. The value of the restricted stock award for fiscal 2020 is $60,000. To account for the partial year beginning on February 1, 2019 and continuing through the 2019 annual meeting, and thereby provide for the alignment of the timing of annual grants of restricted stock under the New Program with the election of directors at the annual meeting, a total of 4,340 shares of restricted stock were granted to the non-employee directors on February 1, 2019. A total of 11,560 shares were awarded to the non-employee directors as compensation under the New Program in the second quarter of fiscal 2020. Other than the shares granted on February 1, 2019, which vested on June 1, 2019, shares of restricted stock granted under the New Program will become vested on the first anniversary of the date of grant, conditioned upon the recipient’s continued service on the Board through that date.

In March 2019, the Company granted 47,474 RSUs and 50,148 PSUs to certain key employees.

Share-based compensation expense was recognized as follows:

 

     Three Months Ended      Nine Months Ended  
(In thousands)    November 2,
2019
     October 27,
2018
     November 2,
2019
     October 27,
2018
 

Stock Options

   $  148      $  215      $ 487      $ 571  

Restricted Stock Awards and Restricted Stock Units

     371        290        1,074        757  

Employee Stock Purchase Plan

     6        5        15        11  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 525      $ 510      $  1,576      $  1,339  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

19


Table of Contents

Stock Options

There were no stock options granted during the nine months ended November 2, 2019. The fair value of stock options granted during the nine months ended October 27, 2018 were estimated using the following assumptions:

 

     Nine Months Ended  
     October 27,
2018
 

Risk Free Interest Rate

     2.6

Expected Volatility

     39.3

Expected Life (in years)

     9.0  

Dividend Yield

     1.5

There were no stock options granted during the three month period ended October 27, 2018. The weighted average fair value per share for stock options granted was $7.41 during the nine month period ended October 27, 2018.

Aggregated information regarding stock option activity for the nine months ended November 2, 2019 is summarized below:

 

     Number of
Options
     Weighted Average
Exercise Price
 

Outstanding at January 31, 2019

     771,145      $ 14.30  

Granted

     —          —    

Exercised

     (55,175      11.68  

Forfeited

     (8,275      16.72  

Canceled

     (400      6.22  
  

 

 

    

 

 

 

Outstanding at November 2, 2019

     707,295      $ 14.48  
  

 

 

    

 

 

 

Set forth below is a summary of options outstanding at November 2, 2019:

 

Outstanding

     Exercisable  

Range of

Exercise prices

   Number
of
Shares
     Weighted-
Average
Exercise
Price
     Weighted-
Average
Remaining
Contractual Life
     Number
of
Shares
     Weighted-
Average
Exercise
Price
     Weighted
Average
Remaining
Contractual
Life
 

$5.00-10.00

     55,881      $ 7.97        2.4        55,881      $ 7.97        2.4  

$10.01-15.00

     414,814      $ 13.62        6.1        326,794      $ 13.64        5.6  

$15.01-20.00

     236,600      $ 17.53        8.1        112,795      $ 17.08        7.8  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     707,295      $ 14.48        6.5        495,470      $ 13.78        5.8  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

As of November 2, 2019, there was approximately $0.9 million of unrecognized compensation expense related to stock options which is expected to be recognized over a weighted average period of approximately 1.7 years.

Restricted Stock Units (“RSUs”), Performance Based Restricted Stock Units (“PSUs”) and Restricted Stock Awards (“RSAs”)

Aggregated information regarding RSU, PSU and RSA activity for the nine months ended November 2, 2019 is summarized below:

 

     RSUs, PSUs &
RSAs
     Weighted Average
Grant Date Fair Value
 

Outstanding at January 31, 2019

     133,667      $ 13.99  

Granted

     113,522        20.16  

Vested

     (55,180      16.62  

Forfeited

     (2,100      19.45  
  

 

 

    

 

 

 

Outstanding at November 2, 2019

     189,909      $ 16.85  
  

 

 

    

 

 

 

 

20


Table of Contents

As of November 2, 2019, there was approximately $2.5 million of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of 0.9 years.

Employee Stock Purchase Plan

AstroNova has an Employee Stock Purchase Plan allowing eligible employees to purchase shares of common stock at a 15% discount from fair value on the first or last day of an offering period, whichever is less. A total of 247,500 shares were reserved for issuance under this plan. During the nine months ended November 2, 2019 and October 27 2018, there were 5,441 and 3,912 shares, respectively, purchased under this plan. As of November 2, 2019, 28,412 shares remain available.

Note 14 – Income Taxes

The Company’s effective tax rates for the period are as follows:

 

     Three Months
Ended
    Nine Months
Ended
 

Fiscal 2020

     (118.2 )%      5.5

Fiscal 2019

     22.3     23.4

The Company determines its estimated annual effective tax rate at the end of each interim period based on full-year forecasted pre-tax income and facts known at that time. The estimated annual effective tax rate is applied to the year-to-date pre-tax income at the end of each interim period with the cumulative effect of any changes in the estimated annual effective tax rate being recorded in the fiscal quarter in which the change is determined. The tax effect of significant unusual items is reflected in the period in which they occur.

During the three months ended November 2, 2019, the Company recognized an income tax benefit of approximately $247,000. The effective tax rate in this period was directly impacted by 1) a reduction in forecasted operating results for our fiscal 2020 as compared to operating results forecasted at the end of our second quarter of fiscal 2020, 2) a $306,000 tax benefit related to the reversal of previously uncertain tax positions due to the finalization of an IRS audit and 3) an $18,000 tax benefit arising from windfall tax benefits related to the Company’s stock. During the three months ended October 27, 2018, the Company recognized an income tax expense of approximately $407,000. The effective tax rate in this period was directly impacted by a $98,000 benefit arising from windfall tax benefits related to the Company’s stock.

During the nine months ended November 2, 2019, the Company recognized an income tax expense of approximately $182,000. The effective tax rate in this period was directly impacted by 1) a $359,000 tax benefit related to the reversal of previously uncertain tax positions due to the finalization of an IRS audit and the expiration of the statute of limitations on previously uncertain tax positions and 2) a $251,000 tax benefit arising from windfall tax benefits related to the Company’s stock. During the nine months ended October 27, 2018, the Company recognized an income tax expense of approximately $1,046,000. The effective tax rate in this period was directly impacted by a $210,000 benefit arising from windfall tax benefits related to the Company’s stock and a $78,000 tax benefit related to the expiration of the statute of limitations on a previously uncertain tax position.

The Company maintains a valuation allowance on some of its deferred tax assets in certain jurisdictions. A valuation allowance is required when, based upon an assessment of various factors, including recent operating loss history, anticipated future earnings, and prudent and reasonable tax planning strategies, it is more likely than not that some portion of the deferred tax assets will not be realized.

Unrecognized tax benefits represent the difference between tax positions taken or expected to be taken in a tax return and the benefits recognized for financial reporting purposes. As of November 2, 2019, the Company’s cumulative unrecognized tax benefits totaled $360,000 compared to $618,000 as of January 31, 2019. Besides the expiration of the statute of limitations on a previously uncertain tax position and finalization of an IRS audit, there were no other developments affecting unrecognized tax benefits during the quarter ended November 2, 2019.

Note 15 – Segment Information

AstroNova reports two segments: Product Identification and Test & Measurement. The Company evaluates segment performance based on the segment profit before corporate expenses.

 

21


Table of Contents

Summarized below are the Revenue and Segment Operating Profit for each reporting segment:

 

     Three Months Ended     Nine Months Ended  
     Revenue      Segment Operating Profit     Revenue      Segment Operating Profit  

(In thousands)

   November 2,
2019
     October 27,
2018
     November 2,
2019
    October 27,
2018
    November 2,
2019
     October 27,
2018
     November 2,
2019
    October 27,
2018
 

Product Identification

   $ 21,749      $ 21,684      $ 1,880     $ 2,014     $ 67,484      $ 63,407      $ 6,990     $ 5,833  

T&M

     11,569        12,512        1,397       3,184       35,483        36,083        5,533       8,256  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total

   $ 33,318      $ 34,196        3,277       5,198     $ 102,967      $ 99,490        12,523       14,089  
  

 

 

    

 

 

        

 

 

    

 

 

      

Corporate Expenses

           2,830       2,836             8,445       8,298  
        

 

 

   

 

 

         

 

 

   

 

 

 

Operating Income

           447       2,362             4,078       5,791  

Other Expense, Net

           (238     (538           (788     (1,320
        

 

 

   

 

 

         

 

 

   

 

 

 

Income Before Income Taxes

           209       1,824             3,290       4,471  

Income Tax (Benefit) Provision

           (247     407             182       1,046  
        

 

 

   

 

 

         

 

 

   

 

 

 

Net Income

         $ 456     $ 1,417           $ 3,108     $ 3,425  
        

 

 

   

 

 

         

 

 

   

 

 

 

Note 16 – Fair Value

Assets and Liabilities Recorded at Fair Value on a Recurring Basis

The following tables provide a summary of the financial assets and liabilities that are measured at fair value as of November 2, 2019 and January 31, 2019:

 

Assets measured at fair value:

   Fair value measurement at
November 2, 2019
     Fair value measurement at
January 31, 2019
 
(In thousands)    Level 1      Level 2      Level 3      Total      Level 1      Level 2      Level 3      Total  

Interest Rate Swap Contract (included in Other Assets)

   $ —        $ —        $ —        $ —        $ —        $ 85      $ —        $ 85  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Assets

   $ —        $ —        $ —        $ —        $ —        $ 85      $ —        $ 85  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities measured at fair value:

   Fair value measurement at
November 2, 2019
     Fair value measurement at
January 31, 2019
 
(In thousands)    Level 1      Level 2      Level 3      Total      Level 1      Level 2      Level 3      Total  

Cross-Currency Interest Rate Swap Contract (included in Other Long-Term Liabilities)

   $ —        $ 329      $ —        $ 329      $ —        $ 600      $ —        $ 600  

Interest Rate Swap Contract (included in Other Long-Term Liabilities)

     —          88        —          88        —          —          —          —    

Earnout Liability (included in Other Long-Term Liabilities)

     —          —          14        14        —          —          14        14  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Liabilities

   $ —        $ 417      $ 14      $ 431      $ —        $ 600      $ 14      $ 614  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

We use the market approach to measure fair value of our derivative instruments. Derivative instruments were measured at fair value using readily observable market inputs, such as quotations on interest rates and foreign exchange rates, and are classified as Level 2 because they are over-the-counter contracts with a bank counterparty that are not traded in an active market.

 

22


Table of Contents

The fair value of the earnout liability incurred in connection with the Company’s acquisition of TrojanLabel was determined using the option approach methodology, which includes using significant inputs that are not observable in the market and therefore classified as Level 3. Key assumptions in estimating the fair value of the contingent consideration liability included (1) the estimated earnout targets over the next seven years, (2) the probability of success (achievement of the various contingent events) and (3) a risk-adjusted discount rate used to adjust the probability-weighted earnout payments to their present value. At each reporting period, the contingent consideration liability is recorded at its fair value with changes reflected in general and administrative expense in the condensed consolidated statements of operations. There was no change in the fair value of the earnout liability for the nine months ended November 2, 2019.

Assets and Liabilities Not Recorded at Fair Value

The Company’s long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:

 

     November 2, 2019  
     Fair Value Measurement      Carrying
Value
 

(In thousands)

   Level 1      Level 2      Level 3      Total  

Long-Term Debt and related current maturities

   $ —        $ —        $ 14,545      $ 14,545      $ 14,244  
     January 31, 2019  
     Fair Value Measurement      Carrying
Value
 

(In thousands)

   Level 1      Level 2      Level 3      Total  

Long-Term Debt and related current maturities

   $ —        $ —        $ 18,857      $ 18,857      $ 18,242  

The fair value of the Company’s long-term debt, including the current portion, is estimated by discounting the future cash flows using current interest rates at which similar loans with the same maturities would be made to borrowers with similar credit ratings and is classified as Level 3.

Note 17 – Subsequent Event

On December 9, 2019, the Company and its wholly owned Danish subsidiaries, ANI ApS and TrojanLabel ApS (the “Parties”), entered into a Fourth Amendment (the “Fourth Amendment”) to the Credit Agreement dated as of February 28, 2017 between the Parties and Bank of America, N.A. (as previously amended, the “Credit Agreement”). The Fourth Amendment amends the Credit Agreement to, among other things, (i) increase the aggregate amount available for borrowings under the revolving line of credit prior to November 1, 2020 from $10.0 million to $17.5 million and (ii) modify the financial covenants with which the Company must comply thereunder by excluding certain capital expenditures from the calculation of the Company’s consolidated fixed charge coverage ratio, providing that the minimum consolidated fixed charge coverage ratio covenant will be suspended through the second quarter of fiscal 2021, and adding a minimum consolidated EBITDA covenant commencing with the fourth quarter of fiscal 2020 and continuing through the second quarter of fiscal 2021.

 

23


Table of Contents
Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Business Overview

This section should be read in conjunction with the AstroNova condensed consolidated financial statements included elsewhere herein and our Annual Report on Form 10-K for the fiscal year ended January 31, 2019.

AstroNova is a multi-national enterprise that leverages its proprietary data visualization technologies to design, develop, manufacture, distribute and service a broad range of products that acquire, store, analyze and present data in multiple formats. The Company organizes its structure around a core set of competencies, including research and development, manufacturing, service, marketing and distribution. It markets and sells its products and services through the following two segments:

 

   

Product Identification (“PI”) – offers digital label printers, over-printers, labeling software, spare parts, service contracts and related printing supplies such as pressure sensitive labels, tags, inks, toners and thermal transfer ribbons used in those product identification digital printers.

 

   

Test and Measurement (“T&M”) – offers a suite of products and services that acquire data from local and networked data streams and sensors as well as wired and wireless networks. The recorded data is processed and analyzed and then stored and presented in various visual output formats. The T&M segment also includes a line of aerospace printers that are used to print hard copies of data required for the safe and efficient operation of aircraft, including navigation maps, arrival and departure procedures, flight itineraries, weather maps, performance data, passenger data, and various air traffic control data. Aerospace products also include Ethernet switches, which are used in military aircraft and military vehicles to connect multiple computers or Ethernet devices.

The Company markets and sells its products and services globally through a diverse distribution structure of direct sales personnel, manufacturers’ representatives and authorized dealers that deliver a full complement of branded products and services to customers in our respective markets. Our growth strategy centers on organic growth through product innovation made possible by research and development initiatives, as well as strategic acquisitions that fit into or complement existing core businesses.

 

24


Table of Contents

Results of Operations

Three Months Ended November 2, 2019 vs. Three Months Ended October 27, 2018

Revenue by segment and current quarter percentage change over the prior year for the three months ended November 2, 2019 and October 27, 2018 were:

 

(Dollars in thousands)

   November 2,
2019
     As a
% of
Revenue
    October 27,
2018
     As a
% of
Revenue
    % Change
Over
Prior Year
 

Product Identification

   $ 21,749        65.3   $ 21,684        63.4     0.3

T&M

     11,569        34.7     12,512        36.6     (7.5 )% 
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total

   $ 33,318        100.0    $ 34,196        100.0      (2.6 )% 
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Revenue for the third quarter of the current year was $33.3 million, representing a decrease compared to the previous year third quarter revenue of $34.2 million. Revenue through domestic channels for the third quarter of the current year was $21.8 million, an increase of 1.3% over the prior year’s third quarter. International revenue for the third quarter of the current year was $11.5 million, representing 34.5% of AstroNova’s third quarter revenue and reflects a 9.2% decrease over the previous year third quarter primarily as a result of weaker demand from a few customers in Asia in the Product Identification segment and a global slowdown in demand for certain aircraft models in the T&M segment. Current year third quarter international revenue includes an unfavorable foreign exchange rate impact of $0.3 million.

Hardware revenue in the current quarter was $12.2 million, a 7.1% decrease compared to the prior year’s third quarter revenue of $13.1 million. The current quarter decrease in hardware revenue is primarily due to the decline in aerospace printer sales related to the Honeywell product lines within the T&M segment. This decline is a result of the ripple effects of the Boeing 737 Max grounding, due in part to reductions in new aircraft shipments, as well as the delay of retrofit printer upgrade orders for earlier 737 models so that those planes could remain in service. The decline of aerospace printer hardware sales in the T&M segment was partly offset by an increase in sales of data acquisition recorders and increased sales for the ToughSwitch product line. The current quarter overall decline in hardware sales was also tempered by an increase in PI segment hardware sales as the product launch of the new QL -300 provided a significant contribution to third quarter revenue, as did sales of TrojanLabel printers, which experienced continued growth during the current quarter.

Supplies revenue in the current quarter was $17.7 million, a 2.5% decrease over prior year’s third quarter supplies revenue of $18.1 million. The decrease in the current quarter supplies revenue as compared to the third quarter of the prior year is primarily attributable to a decrease in revenue of QuickLabel product supplies in the Product Identification segment. The decrease in supplies revenue for the current quarter was slightly offset by an increase in TrojanLabel product supplies revenue within the Product Identification segment.

Service and other revenue was $3.5 million in the current quarter, a 17.0% increase over the prior year revenue of $3.0 million. The current quarter increase is primarily due to an increase in parts and repair revenue related to the AstroNova aerospace printer product lines in the T&M segment.

Current year third quarter gross profit was $12.3 million, an 11.6% decrease compared to prior year third quarter gross profit of $13.9 million. The Company’s current quarter gross profit margin of 36.9% reflects a 380 basis point decline from the prior year’s third quarter gross profit margin of 40.7%. The lower gross profit and related profit margin for the current quarter compared to the prior year’s third quarter is primarily attributable to decreased revenue and unfavorable product mix in both the PI and T&M segments.

Operating expenses for the current quarter were $11.9 million, a 2.6% increase compared to the prior year third quarter operating expenses of $11.5 million. Specifically, current quarter selling and marketing expenses were $6.9 million, a 5.4% increase compared to $6.6 million in the third quarter of the prior year, as the increases in wages, travel, entertainment and trade show expenditures were offset by a decline in employee benefits for the current year. Both general and administrative expenses of $2.8 million and research and development (“R&D”) expenses of $2.1 million remained unchanged from the third quarter of the prior year. R&D spending as a percentage of revenue for the current quarter of 6.2% remained consistent with the same period of the prior year.

Other expense in the third quarter of fiscal 2020 was $0.2 million compared to $0.5 million in the third quarter of the prior year. Current quarter other expense primarily includes interest expense on the Company’s debt and revolving line of credit of $0.2 million. Other expense for the third quarter of fiscal 2019 consisted primarily of interest expense on debt of $0.2 million and net foreign exchange loss of $0.3 million.

 

25


Table of Contents

The benefit for federal, state and foreign income taxes for the third quarter of the current year is $0.2 million, resulting in an effective tax rate of negative 118.2%. This rate was impacted by a reduction in internally forecasted operating results for our fiscal 2020 as compared to operating results at the end of the second quarter of fiscal 2020, a $0.3 million tax benefit related to the reversal of previously uncertain tax positions due to the finalization of an IRS audit and an $18,000 tax benefit arising from windfall tax benefits related to the Company’s stock. This compares to the prior year’s third quarter tax provision of $0.4 million, which reflected a benefit of $0.1 million related to windfall tax benefits related to the Company’s stock and an effective tax rate of 22.3%.

The Company reported net income of $0.5 million or $0.06 per diluted share for the third quarter of the current year. On a comparable basis, net income for the prior year’s third quarter was $1.4 million or $0.20 per diluted share. Return on revenue was 1.4% for the third quarter of fiscal 2020 compared to 4.1% for the third quarter of fiscal 2019.

Nine Months Ended November 2, 2019 vs. Nine Months Ended October 27, 2018

Revenue by product group and current period percentage change over the prior year for the nine months ended November 2, 2019 and October 27, 2018 were:

 

(Dollars in thousands)

   November 2,
2019
     As a
% of
Revenue
    October 27,
2018
     As a
% of
Revenue
    % Change
Over
Prior Year
 

Product Identification

   $ 67,484        65.5   $ 63,407        63.7     6.4

T&M

     35,483        34.5     36,083        36.3     (1.7 )% 
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total

   $ 102,967        100.0   $ 99,490        100.0     3.5
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Revenue for the first nine months of the current year was $103.0 million, representing a 3.5% increase compared to the previous year’s first nine months of revenue of $99.5 million. Revenue through domestic channels for the first nine months of the current year was $64.5 million, an increase of 6.1% from prior year domestic revenue of $60.8 million. International revenue for the first nine months of the current year was $38.5 million, a slight decrease from the previous year international revenue of $38.7 million. The current year’s first nine months of international revenue reflected an unfavorable foreign exchange rate impact of $1.2 million.

Hardware revenue in the first nine months of the current year was $37.5 million, a 1.3% decrease compared to the prior year’s first nine months of revenue of $38.0 million. The decrease in hardware sales is primarily related to the decline in the aerospace printer product line related to the Honeywell Agreement in the T&M segment. This decline is a result of the ripple effects of the Boeing 737 Max grounding, due in part to reductions in new aircraft shipments, as well as lower retrofit printer upgrade orders for older 737 models so that those planes could remain in service. This decline of hardware sales in the T&M segment was slightly offset by an increase in sales of data acquisition recorders and other aerospace printers. The overall decline in hardware revenue for the current year was also tempered by an increase in PI segment hardware sales, as the product launch of the new QL -300 provided a significant contribution to current year revenue as did sales of the TrojanLabel printers which also experienced continued growth during the current year.

Supplies revenue in the first nine months of the current year was $55.5 million, representing a 5.3% increase over the prior year’s first nine months revenue of $52.7 million. The current year increase in supplies revenue is due primarily to the increase in inkjet printer supplies and label sales, tempered by lower thermal film and electrophotographic supplies revenue in the Product Identification segment.

Service and other revenues were $10.0 million in the first nine months of the current year, a 13.4% increase compared to the prior year’s first nine months service and other revenues of $8.8 million. The current year increase is primarily due to an increase in repairs and parts revenues in the AstroNova aerospace product line and an increase in customer demand for parts in the data recorder product line. Also contributing to the current year increase were sales of parts in the Product Identification segment as a result of the increase in the installed base of printers currently in the field. Current year first nine months gross profit was $38.5 million, a 2.3% decrease from prior year’s first nine months gross profit of $39.4 million. The Company’s gross profit margin of 37.4% in the current year reflects a decrease from the prior year’s first nine months gross profit margin of 39.6%. The lower gross profit margin for the current year compared to the prior year is primarily due to higher period costs and adverse product mix.

Operating expenses for the first nine months of the current fiscal year were $34.4 million, a 2.4% increase compared to the prior year’s first nine months operating expenses of $33.6 million. Selling and marketing expenses for the current year of $20.1 million increased 3.3% compared to the previous year’s first nine months due primarily to an increase in wages, outside services, and travel expenses which were slightly offset by lower commissions and benefits. General and Administrative (“G&A”) expenses for the first nine months of the current year were $8.4 million, a 1.8% increase compared to the prior year’s first nine months G&A expenses of $8.3 million. The increase in G&A expenses in the current year was primarily due to an increase in outside service fees and corporate related expenditures, partially offset by a decrease in employee benefits. R&D spending in the first nine months of the current year was $5.9 million, a slight increase compared to the prior year’s first nine months spending of $5.8 million. Current year spending on R&D represents 5.7% of revenue compared to the prior year’s first nine months level of 5.9%.

 

26


Table of Contents

Other expense during the first nine months of the current year was $0.8 million compared to $1.3 million in the first nine months of the previous year. Current year other expense includes interest expense of $0.6 million on the Company’s debt and revolving credit line and $0.3 million of net foreign exchange loss which was partially offset by investment and other income of $0.1 million. Other expense during the first nine months of fiscal 2019 includes interest expense on debt of $0.6 million and net foreign exchange loss of $0.8 million which was partially offset by investment and other income of $0.1 million

The Company recognized $0.2 million of income tax expense for the first nine months of the current fiscal year, which includes a $0.4 million tax benefit related to the reversal of previously uncertain tax positions due to the finalization of an IRS audit and the expiration of statute of limitations on previously uncertain tax positions and a $0.3 million tax benefit arising from windfall tax benefits related to the Company’s stock which resulted in a 5.5% effective tax rate. The Company recognized $1.0 million of income tax expense for the first nine months of the prior fiscal year. The 23.4% effective tax rate in that period was directly impacted by a $0.2 million tax benefit arising from windfall tax benefits related to the Company’s stock and a $0.1 million tax benefit related to the expiration of the statute of limitations on a previously uncertain tax position.

The Company reported net income of $3.1 million, or $0.43 per diluted share, for the first nine months of the current year. On a comparable basis, net income for the first nine months of the prior year was $3.4 million, or $0.49 per diluted share, which included $0.8 million of after-tax income, or $0.12 per diluted share, as a result of a change in accounting estimates in the prior year’s first quarter for product cost and operating expenses related to a transition services agreement entered into with Honeywell in connection with the Honeywell Agreement. In addition, during the first quarter of fiscal 2019, a change in accounting estimate for revenue subject to customer rebates under the Honeywell Agreement increased net income by $0.3 million or $0.05 per diluted share. Return on revenue was 3.0% for the first nine months of fiscal 2020 compared to 3.4% for the first nine months of fiscal 2019.

Segment Analysis

The Company reports two segments: Product Identification and Test & Measurement and evaluates segment performance based on the segment profit before corporate and financial administration expenses. Summarized below are the Revenue and Segment Operating Profit for each reporting segment:

 

     Three Months Ended     Nine Months Ended  
     Revenue      Segment Operating Profit     Revenue      Segment Operating Profit  

(In thousands)

   November 2,
2019
     October 27,
2018
     November 2,
2019
    October 27,
2018
    November 2,
2019
     October 27,
2018
     November 2,
2019
    October 27,
2018
 

Product Identification

   $ 21,749      $ 21,684      $ 1,880     $ 2,014     $ 67,484      $ 63,407      $ 6,990     $ 5,833  

T&M

     11,569        12,512        1,397       3,184       35,483        36,083        5,533       8,256  
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total

   $ 33,318      $ 34,196        3,277       5,198     $ 102,967      $ 99,490        12,523       14,089  
  

 

 

    

 

 

        

 

 

    

 

 

      

Corporate Expenses

           2,830       2,836             8,445       8,298  
        

 

 

   

 

 

         

 

 

   

 

 

 

Operating Income

           447       2,362             4,078       5,791  

Other Expense, Net

           (238     (538           (788     (1,320
        

 

 

   

 

 

         

 

 

   

 

 

 

Income Before Income Taxes

           209       1,824             3,290       4,471  

Income Tax (Benefit) Provision

           (247     407             182       1,046  
        

 

 

   

 

 

         

 

 

   

 

 

 

Net Income

         $ 456     $ 1,417           $ 3,108     $ 3,425  
        

 

 

   

 

 

         

 

 

   

 

 

 

Product Identification

Total current quarter revenue from the Product Identification segment of $21.7 million was comparable to revenue for the same period of the prior year. Current quarter revenue includes increases in hardware and supplies revenue within the TrojanLabel product group, as well as a significant contribution from the introduction of the new QL -300 printer in the QuickLabel product group, slightly offset by declines in some of the Company’s inkjet printer product lines. Product Identification’s current quarter segment operating profit was $1.9 million, reflecting a profit margin of 8.6%. This compares to the prior year’s third quarter segment profit of $2.0 million and related profit margin of 9.3%. The slight decrease in Product Identification current year third quarter operating segment operating margin is primarily due to higher operating expenses and adverse product mix.

 

27


Table of Contents

Revenues from the Product Identification segment increased 6.4% to $67.5 million in the first nine months of the current year from $63.4 million in the same period of the prior year. The current year increase is primarily attributable to strong demand for ink jet supplies in the first quarter from Asian customers, which subsequently declined. Also contributing to the increase in revenue for the current year was an increase in service and other revenue. Hardware revenue in the PI segment remained fairly constant compared to the prior year; however the segment did experience a significant revenue contribution from the introduction of QuickLabel’s new QL -300 printer, as well as double-digit growth in revenue from sales of both QuickLabel’s monochromatic printers and TrojanLabel’s T2-C printers. This growth was tempered by lower sales of other inkjet color printers within the QuickLabel product group. Product Identification current year segment operating profit was $7.0 million with a profit margin of 10.4%, compared to the prior year segment operating profit of $5.8 million and related profit margin of 9.2 %. The increase in current year segment operating profit and margin is primarily due to higher sales and product mix early in the year.

Test & Measurement—T&M

Revenue from the T&M segment was $11.6 million for the third quarter of the current fiscal year, representing a 7.5% decrease compared to revenue of $12.5 million for the same period in the prior year. The current quarter revenue decrease is due to the decline in the aerospace printer product line acquired from Honeywell in fiscal 2018 as a result of the ripple effects of the Boeing 737 Max grounding which resulted in part to new aircraft shipment reductions as well as delays of several retrofit printer upgrade orders for earlier 737 models so that those planes could remain in service. T&M’s third quarter segment operating profit was $1.4 million, reflecting a profit margin of 12.1%, a decrease compared to the prior year segment operating profit of $3.2 million and related operating margin of 25.4%. The decrease in segment operating profit and related margin were due to lower sales revenue, adverse product mix and higher manufacturing and period costs.

Revenue from the T&M segment was $35.5 million for the first nine months of the current fiscal year, a 1.7% decrease compared to sales of $36.1 million for the same period in the prior year. The decrease in revenue for the first nine months of the current year is also primarily due to the decline in the aerospace printer product line acquired from Honeywell as a result of the impact of the Boeing 737 Max grounding. The decline was slightly offset by an increase in the hardware product line as a result of increased sales of T&M data recorders and AstroNova aerospace printers, both experiencing double digit growth in the current year, and an increase in parts and repair revenue. The segment’s first nine months operating profit of $5.5 million resulted in a 15.6% profit margin compared to the prior year segment operating profit of $8.3 million and related operating margin of 22.9%. The lower segment operating profit and related margin for the current year is due to lower revenue, adverse product mix and higher manufacturing costs and operating expenses.

Financial Condition and Liquidity

Overview

Generally, our primary sources of liquidity are cash generated from operating activities and borrowings under our revolving credit facility, as described below, which we use to supplement cash generated from operating activities and to fund a portion of our capital expenditures, contractual contingent consideration obligations, and future acquisitions. We believe that our current level of cash and short-term financing capabilities along with future cash flows from operations will be sufficient to meet our operating and capital needs for at least the next 12 months.

Our cash and cash equivalents at the end of the third quarter were $4.5 million. During the third quarter of the current year, the Company borrowed an additional $3.0 million on its revolving credit facility. At November 2, 2019, under its existing revolving credit facility, the Company had an outstanding balance of $6.5 million and $3.5 million remaining available for borrowing.

The Company’s backlog decreased 18.8% from year-end to $20.8 million at the end of the third quarter of fiscal 2020.

 

28


Table of Contents

Indebtedness

In fiscal 2018, the Company and the Company’s wholly owned Danish subsidiaries, ANI ApS and TrojanLabel ApS, entered into a credit agreement with Bank of America, N.A. (the “Lender”), which, as amended through November 2, 2019 (the “Credit Agreement”), provides for a secured credit facility consisting of a term loan to ANI ApS in the principal amount of $9.2 million and a term loan to the Company in the principal amount of $15.0 million. The Credit Agreement also provides for a $10.0 million revolving credit facility for the Company.

Both term loans bear interest at a rate per annum equal to the LIBOR rate plus a margin that varies within a range of 1.0% to 1.5% based on the Company’s consolidated leverage ratio.

In connection with our entry into the Credit Agreement, ANI ApS entered into a hedging agreement to manage the variable interest rate risk and currency risk associated with its payments in respect to the term loan. Under this combined arrangement, payments of principal and interest with respect to approximately $8.9 million of the principal of the term loan will be made in Danish Kroner, and interest on such principal amount will be payable at a fixed rate of 0.67% per annum for the entire term, subject only to potential changes based on the Company’s consolidated leverage ratio. Additionally, the Company entered into a hedging agreement to manage the variable interest rate risk associated with its payments with respect to the $15.0 million term loan. Under this combined arrangement, interest will be payable at a fixed rate of 2.04% per annum for the entire term, plus an incremental margin of 1.0% to 1.5%, based on the Company’s consolidated leverage ratio.

Revolving credit loans may be borrowed, at the Company’s option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner. Amounts borrowed under the revolving credit facility bear interest at a rate per annum equal to, at the Company’s option, either (a) the LIBOR rate (or, in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.0% to 1.5% based on the Company’s consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal funds’ rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate or (iii) the LIBOR rate plus 1.00%, plus a margin that varies within a range of 0.0% to 0.5% based on the Company’s consolidated leverage ratio. The Company is required to pay a commitment fee on the undrawn portion of the revolving credit facility at the rate of 0.25% per annum. Outstanding borrowings under the revolving credit line during fiscal 2020 bear interest at a weighted average annual rate of 5.26% and the Company has paid $93,000 of interest expense for revolving credit line borrowings for the nine months ended November 2, 2019.

The obligations of ANI ApS in respect of the $9.2 million term loan are guaranteed by the Company and TrojanLabel ApS. The Company’s obligations in respect of the $15.0 million term loan, revolving credit facility and its guarantee in respect of the ANI ApS term loan are secured by substantially all of the assets of the Company (including a pledge of a portion of the equity interests held by the Company in ANI ApS and the Company’s wholly owned German subsidiary, AstroNova GmbH), subject to certain exceptions.

The Lender is entitled to accelerate repayment of the loans and to terminate its revolving credit commitment under the Credit Agreement upon the occurrence of any of various customary events of default.

 

29


Table of Contents

The Parties must comply with various customary financial and non-financial covenants under the Credit Agreement.

On December 9, 2019, the Company, ANI ApS, TrojanLabel ApS and the Lender, entered into a Fourth Amendment (the “Fourth Amendment”) to the Credit Agreement. Refer to Part II, Item 5 Other Information for further details on the Fourth Amendment and resulting changes to the terms of the Credit Agreement.

The Company believes it is in compliance with all of the covenants in the amended Credit Agreement.

Cash Flow

The Company’s statements of cash flows for the nine months ended November 2, 2019 and October 27, 2018 are included on page 8 of this report. Net cash provided by operating activities was $1.0 million for the first nine months of fiscal 2020 compared to $2.5 million for the same period of the previous year. The decrease in net cash provided by operations for the first nine months of the current year is primarily due to the decrease in net income, and an increase in cash used for working capital. The combination of changes in accounts receivable, inventory, income taxes, accounts payable and accrued expenses negatively impacted cash by $8.4 million for the first nine months of fiscal 2020, compared to $6.8 million for the same period in fiscal 2019.

The accounts receivable balance decreased to $22.1 million at the end of the third quarter compared to $23.5 million at year end. The $1.4 million decrease in the accounts receivable balance from year end is directly related to the decrease in sales for the third quarter of the current year as compared to third quarter sales in fiscal 2019.

The inventory balance was $35.6 million at the end of the third quarter of fiscal 2020, compared to $30.2 million at year end and inventory days on hand increased to 152 days at the end of the current quarter from 120 days at the prior year end. The current period increase in inventory and related days on hand is due to lower forecasted sales, as well as a buildup of inventory for new product launches in our Product Identification segment. Also contributing to the inventory increase were delayed shipments to customers in the Product Identification segment and last time buy parts and safety stock increases in the T&M segment.

The net decreased cash position at November 2, 2019 primarily resulted from principal payments of long-term debt and the guaranteed royalty obligation of $4.0 million and $1.4 million, respectively; cash used to acquire property, plant and equipment of $2.4 million and dividends paid of $1.5 million, offset by increased cash provided by current period borrowing on the Company’s existing revolving credit facility of $5.0 million.

Contractual Obligations, Commitments and Contingencies

There have been no material changes to our contractual obligations as disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2019, other than those which occur in the ordinary course of business.

Critical Accounting Policies, Commitments and Certain Other Matters

The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosure of commitments and contingencies at the date of the condensed consolidated financial statements and reported amounts of revenue and expenses during the reporting period. We base these estimates and judgments on factors we believe to be relevant, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

 

30


Table of Contents

The process of determining significant estimates is fact-specific and takes into account factors such as historical experience, current and expected economic conditions, product mix, and in some cases, actuarial and appraisal techniques. We constantly re-evaluate these significant factors and make adjustments where facts and circumstances dictate.

While we believe that the factors considered provide a meaningful basis for the accounting policies applied in the preparation of the condensed consolidated financial statements, we cannot guarantee that our estimates and assumptions will be accurate. As the determination of these estimates requires the exercise of judgment, actual results may differ from those estimates, and such differences may be material to our condensed consolidated financial statements. Except for the changes resulting from the adoption of the new lease accounting standard during the period, there have been no material changes to the application of critical accounting policies as disclosed in our Annual Report on Form 10-K for the fiscal year ended January 31, 2019. See Note 11, Leases, in Notes to the Condensed Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q, for an update on our lease accounting policy.

Forward-Looking Statements

This Quarterly Report on Form 10-Q may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Factors which could cause actual results to differ materially from those anticipated include, but are not limited to (a) general economic, financial and business conditions; (b) declining demand in the test and measurement markets, especially defense and aerospace; (c) competition in the specialty printer industry; (d) ability to develop market acceptance of our products and effective design of customer required features; (e) competition in the data acquisition industry; (f) the impact of changes in foreign currency exchange rates on the results of operations; (g) the ability to successfully integrate acquisitions and realize benefits from divestitures; (h) the business abilities and judgment of personnel and changes in business strategy; (i) the efficacy of research and development investments to develop new products; (j) the launching of significant new products which could result in unanticipated expenses; (k) bankruptcy or other financial problems at major suppliers or customers that could cause disruptions in the Company’s supply chain or difficulty in collecting amounts owed by such customers; (l) any technology disruption or delay in implementing new technology; (m) a material security breach or cybersecurity attack impacting our business and our relationship with customers and (n) other risks included under “Item 1A-Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2019. We assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

During the nine months ended November 2, 2019, there were no material changes to our market risk disclosures as set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the year ended January 31, 2019.

 

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management has evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (Exchange Act). Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to have materially affected, our internal control over financial reporting.

 

31


Table of Contents

PART II. OTHER INFORMATION

 

Item 1.

Legal Proceedings

There are no pending or threatened legal proceedings against the Company believed to be material to the financial position or results of operations of the Company.

 

Item 1A.

Risk Factors

In addition to the other information set forth in this Quarterly Report on Form 10-Q, one should carefully consider the factors discussed in Part I, Item 1A “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2019, which could materially affect our business, financial condition or future operating results. The risks described in our Annual Report on 10-K are not the only risks that could affect our business, as additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results as well as adversely affect the value of our common stock.

There have been no material updates to the risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2019.

 

Item 5.

Other Information

The Company is providing the following information in this Item 5 in lieu of disclosing the information under Items 1.01 and 2.03 of a Current Report on Form 8-K with a due date on or after the date hereof.

On December 9, 2019, the Company, ANI ApS, TrojanLabel ApS and the Lender entered into the Fourth Amendment to the Credit Agreement. The Fourth Amendment amends the Credit Agreement to, among other things, (i) increase the aggregate amount available for borrowings under the revolving line of credit prior to November 1, 2020 from $10.0 million to $17.5 million and (ii) modify the financial covenants with which the Company must comply thereunder by excluding certain capital expenditures from the calculation of the Company’s consolidated fixed charge coverage ratio, providing that the minimum consolidated fixed charge coverage ratio covenant will be suspended through the second quarter of fiscal 2021, and adding a minimum consolidated EBITDA covenant commencing with the fourth quarter of fiscal 2020 and continuing through the second quarter of fiscal 2021.

The description of the Fourth Amendment is qualified in its entirety by reference to the full text of the Fourth Amendment, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

 

32


Table of Contents
Item 6.

Exhibits

 

3A    Restated Articles of Incorporation of the Company and all amendments thereto, filed as Exhibit 3A to the Company’s Quarterly Report on Form 10-Q for the quarter ended April 30, 2016 and incorporated by reference herein.
3B    By-laws of the Company as amended to date, filed as Exhibit 3B to the Company’s Annual Report on Form 10-K/A for the fiscal year ended January 31, 2008 (File no. 000-13200) and incorporated by reference herein.
10.1    Fourth Amendment to Credit Agreement, dated as of December 9, 2019, by and among AstroNova, Inc. ANI ApS, Trojan Label ApS and Bank of America, N.A.
31.1    Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2    Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1    Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2    Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101    The following materials from Registrant’s Quarterly Report on Form 10-Q for the period ended November 2, 2019, formatted in XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Income, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statements of Shareholders’ Equity, (v) the Condensed Consolidated Statements of Cash Flows, and (vi) the Notes to the Condensed Consolidated Financial Statements. Filed electronically herein.

 

33


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    ASTRONOVA, INC.
    (Registrant)
Date: December 10, 2019     By  

/s/ Gregory A. Woods

      Gregory A. Woods,
      President and Chief Executive Officer
      (Principal Executive Officer)
    By  

/s/ David S. Smith

      David S. Smith,
      Vice President, Chief Financial Officer and Treasurer (Principal Accounting Officer and Principal Financial Officer)

 

34


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
11/20/22
1/31/22
11/1/20
12/15/19
Filed on:12/10/19
12/9/19
12/5/19
For Period end:11/2/19
8/3/1910-Q
6/4/193,  4,  8-K,  DEF 14A,  S-8
6/1/19
5/4/1910-Q
2/1/194
1/31/1910-K,  8-K
10/27/1810-Q
7/28/1810-Q
4/28/1810-Q
2/1/184
2/28/178-K
 List all Filings 
Top
Filing Submission 0001193125-19-309951   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 1:24:32.1pm ET